
Vasoglim M 2mg/500mg Tablet ER
Marketer
Vasolife Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Vasoglim M 2mg/500mg Tablet ER
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, lightheadedness, headache, tremors—and how to counteract them. Maintain regular meals and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Vasoglim M 2mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Vasoglim M 2mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vasoglim M 2mg/500mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Vasoglim M 2mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Vasoglim M 2mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vasoglim M 2mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not damage them by chewing, crushing, or breaking. Administer this medication with food.
How Vasoglim M 2mg/500mg Tablet ER works:
Vasoglim M ER tablets (2mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vasoglim M 2mg/500mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vasoglim M 2mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Vasoglim M 2mg/500mg tablets are contraindicated during lactation due to potential infant toxicity.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when prescribing Vasoglim M 2mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Vasoglim M 2mg/500mg Extended-Release tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment duration.
LiverCAUTION
Patients with liver impairment should use Vasoglim M 2mg/500mg Extended-Release tablets cautiously, as dosage modification may be necessary. Individuals with mild to moderate hepatic dysfunction typically begin with a reduced dose; however, this medication is contraindicated in those with severe liver disease. Medical advice is recommended.
What if you forget to take Vasoglim M 2mg/500mg Tablet ER :
Should you forget a dose of Vasoglim M 2mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vasoglim M 2mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
